<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biores Open Access</journal-id>
<journal-id journal-id-type="iso-abbrev">Biores Open Access</journal-id>
<journal-id journal-id-type="publisher-id">biores</journal-id>
<journal-title-group>
<journal-title>BioResearch Open Access</journal-title>
</journal-title-group>
<issn pub-type="ppub">2164-7844</issn>
<issn pub-type="epub">2164-7860</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc.</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27274912</article-id>
<article-id pub-id-type="pmc">4892191</article-id>
<article-id pub-id-type="publisher-id">10.1089/biores.2016.0010</article-id>
<article-id pub-id-type="doi">10.1089/biores.2016.0010</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Comprehensive Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microbiota and Neurological Disorders: A Gut Feeling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Moos</surname>
<given-names>Walter H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="corresp" rid="corr1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Faller</surname>
<given-names>Douglas V.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2,</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harpp</surname>
<given-names>David N.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanara</surname>
<given-names>Iphigenia</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5,</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pernokas</surname>
<given-names>Julie</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Powers</surname>
<given-names>Whitney R.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8,</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steliou</surname>
<given-names>Kosta</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3,</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10,</sup>
</xref>
<xref ref-type="corresp" rid="corr1">
<sup>*</sup>
</xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>Department of Pharmaceutical Chemistry, School of Pharmacy, <institution>University of California San Francisco</institution>, San Francisco, California.</aff>
<aff id="aff2"><label><sup>2</sup></label>Department of Medicine, <institution>Boston University School of Medicine</institution>, Boston, Massachusetts.</aff>
<aff id="aff3"><label><sup>3</sup></label>Cancer Research Center, <institution>Boston University School of Medicine</institution>, Boston, Massachusetts.</aff>
<aff id="aff4"><label><sup>4</sup></label>Department of Chemistry, <institution>McGill University</institution>, Montreal, <country>Canada</country>.</aff>
<aff id="aff5"><label><sup>5</sup></label>Weatherhead Center for International Affairs, <institution>Harvard University</institution>, Cambridge, Massachusetts.</aff>
<aff id="aff6"><label><sup>6</sup></label>Consulate General of Greece in Boston, Boston, Massachusetts.</aff>
<aff id="aff7"><label><sup>7</sup></label>Advanced Dental Associates of New England, Woburn, Massachusetts.</aff>
<aff id="aff8"><label><sup>8</sup></label>Department of Health Sciences, <institution>Boston University</institution>, Boston, Massachusetts.</aff>
<aff id="aff9"><label><sup>9</sup></label>Department of Anatomy, <institution>Boston University School of Medicine</institution>, Boston, Massachusetts.</aff>
<aff id="aff10"><label><sup>10</sup></label><institution>PhenoMatriX, Inc.</institution>, Boston, Massachusetts.</aff>
</contrib-group>
<author-notes>
<corresp id="corr1"><label><sup>*</sup></label>Address correspondence to: Walter H. Moos, PhD, Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, 600 16th Street, Mail Code 2280, Genentech Hall S512D, Mission Bay Campus, San Francisco, CA 94158, E-mail: <email xlink:href="mailto:walter.moos@ucsf.edu">walter.moos@ucsf.edu</email>, <email xlink:href="mailto:moosw@cal.berkeley.edu">moosw@cal.berkeley.edu</email>; <italic>or</italic> Kosta Steliou, PhD, PhenoMatriX, Inc., 9 Hawthorne Place Suite 4R, Boston, MA 02114, E-mail: <email xlink:href="mailto:steliou@bu.edu">steliou@bu.edu</email>, <email xlink:href="mailto:ksteliou@partners.org">ksteliou@partners.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>5</month>
<year>2016</year>
<!--string-date: May 2016-->
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2016</year>
<!--string-date: May 2016-->
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>5</volume>
<issue>1</issue>
<fpage>137</fpage>
<lpage>145</lpage>
<permissions>
<copyright-statement>© Walter H. Moos <italic>et al</italic>. 2016; Published by Mary Ann Liebert, Inc.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access">
<license-p>This Open Access article is distributed under the terms of the Creative Commons License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="biores.2016.0010.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p>In the past century, noncommunicable diseases have surpassed infectious diseases as the principal cause of sickness and death, worldwide. Trillions of commensal microbes live in and on our body, and constitute the human microbiome. The vast majority of these microorganisms are maternally derived and live in the gut, where they perform functions essential to our health and survival, including: digesting food, activating certain drugs, producing short-chain fatty acids (which help to modulate gene expression by inhibiting the deacetylation of histone proteins), generating anti-inflammatory substances, and playing a fundamental role in the induction, training, and function of our immune system. Among the many roles the microbiome ultimately plays, it mitigates against untoward effects from our exposure to the environment by forming a biotic shield between us and the outside world. The importance of physical activity coupled with a balanced and healthy diet in the maintenance of our well-being has been recognized since antiquity. However, it is only recently that characterization of the host–microbiome intermetabolic and crosstalk pathways has come to the forefront in studying therapeutic design. As reviewed in this report, synthetic biology shows potential in developing microorganisms for correcting pathogenic dysbiosis (gut microbiota–host maladaptation), although this has yet to be proven. However, the development and use of small molecule drugs have a long and successful history in the clinic, with small molecule histone deacetylase inhibitors representing one relevant example already approved to treat cancer and other disorders. Moreover, preclinical research suggests that epigenetic treatment of neurological conditions holds significant promise. With the mouth being an extension of the digestive tract, it presents a readily accessible diagnostic site for the early detection of potential unhealthy pathogens resident in the gut. Taken together, the data outlined herein provide an encouraging roadmap toward important new medicines and companion diagnostic platforms in a wide range of therapeutic indications.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title><bold>Key words:</bold> </title>
<kwd>α-lipoic acid</kwd>
<kwd>autism</kwd>
<kwd>dementia</kwd>
<kwd>dysbiosis</kwd>
<kwd>epigenetic</kwd>
<kwd>exercise</kwd>
<kwd>fatty acids</kwd>
<kwd>histone deacetylase</kwd>
<kwd>immune system</kwd>
<kwd>microbiota</kwd>
<kwd>mitochondria</kwd>
<kwd>neurodegenerative</kwd>
<kwd>probiotics</kwd>
<kwd>schizophrenia</kwd>
<kwd>synthetic biology</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<ref-count count="194"></ref-count>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s001" sec-type="intro">
<title>Introduction</title>
<p>In less than 100 years, noncommunicable diseases have surpassed infectious diseases as the principal cause of sickness and death, worldwide.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> One hundred trillion commensal microbes (including the fungal community referred to as the mycobiome)<sup><xref ref-type="bibr" rid="B2">2</xref></sup> that live in and on our body constitute the human microbiome,<sup><xref ref-type="bibr" rid="B3">3</xref></sup> although a recent study<sup><xref ref-type="bibr" rid="B4">4</xref></sup> estimates the overall figure to be much lower. Regardless of the absolute number, the vast majority of these microorganisms live in the gut (microbiota),<sup><xref ref-type="bibr" rid="B5">5</xref></sup> where they perform functions that are essential to our health and survival. They help us digest food<sup><xref ref-type="bibr" rid="B6">6</xref></sup>; participate in the activation of certain drugs<sup><xref ref-type="bibr" rid="B7">7</xref></sup>; produce short-chain fatty acids (SCFAs) that help modulate gene expression by inhibiting deacetylation of histone proteins<sup><xref ref-type="bibr" rid="B8">8–10</xref></sup>; generate molecules that reduce inflammation<sup><xref ref-type="bibr" rid="B11">11</xref></sup>; and play a fundamental role in the induction, basic development, training, and function of our immune system.<sup><xref ref-type="bibr" rid="B12">12–14</xref></sup> Thus, as a whole, the microbiome becomes an integral part of our immune makeup, and is largely inherited from the mother with significant differences consequent to cesarean versus vaginal deliveries.<sup><xref ref-type="bibr" rid="B15">15–20</xref></sup> Among the many roles the microbiome may ultimately play in health and disease, it mitigates against the untoward effects from our exposure to the environment by residing as a biotic barrier between us and the world around us.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B21">21–25</xref></sup></p>
<p>Neuropsychiatric disorders<sup><xref ref-type="bibr" rid="B26">26</xref></sup> are on the increase globally and, of the noncommunicable diseases, stand out as a leading cause of disability.<sup><xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref></sup> Accruing evidence strongly links gut dysbiosis (gut microbiota–host maladaptation) as a risk factor in a wide range of mental illnesses that include neuropsychiatric conditions,<sup><xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B29">29–38</xref></sup> such as autism spectrum disorder (ASD)<sup><xref ref-type="bibr" rid="B39">39–46</xref></sup> and schizophrenia<sup><xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B46">46–49</xref></sup> among them. There are currently no drugs approved that treat the core symptoms of ASD.<sup><xref ref-type="bibr" rid="B50">50</xref></sup> The pathogenic mechanisms underlying schizophrenia, a debilitating mental disorder, are unknown<sup><xref ref-type="bibr" rid="B51">51</xref></sup> and drug therapies used to treat the associated psychotic symptoms have advanced little since the introduction of clozapine in 1960.<sup><xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B53">53</xref></sup></p>
<p>The reported association of mental illness with digestive disturbances dates back to Hippocrates and stands as the single consistently linked comorbidity described in the medical literature from ancient times to the present.<sup><xref ref-type="bibr" rid="B49">49</xref></sup> Although the genesis of our microbiome is predominantly our mother's,<sup><xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B54">54</xref></sup> eventually our microbiome transforms into our own unique signature.<sup><xref ref-type="bibr" rid="B55">55</xref></sup> Changes in the gut microbial composition and function constantly adapt to our diet,<sup><xref ref-type="bibr" rid="B56">56</xref>,<xref ref-type="bibr" rid="B57">57</xref></sup> and the mechanistic relationships between the gut microbiota in the development of the enteric nervous system<sup><xref ref-type="bibr" rid="B58">58</xref></sup> and the preservation of our metabolic health<sup><xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref></sup> are only now beginning to be elucidated.</p>
</sec>
<sec id="s002">
<title>Microbiota-Induced Epigenetics</title>
<p>Advances in genetic editing technologies may help clarify whether it is our genetics that control our epigenome or epigenetics that control the genome—or, more likely, the relationship between the two is mutual.<sup><xref ref-type="bibr" rid="B61">61</xref></sup> There is supporting evidence to suggest that our microbiome plays a fundamental role in this relationship.<sup><xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref></sup> Numerous studies<sup><xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B65">65</xref></sup> show microbe-generated metabolites are intertwined with host cell biochemistry and physiology, and SCFA-mediated cell signaling is a key pathway that gut microbes use to communicate with the host.<sup><xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B66">66–68</xref></sup> Acetate, propionate (propionic acid is also commonly referred to as PPA), butyrate, and pentanoate, having respectively, 2, 3, 4, and 5 carbon atoms are SCFAs (<xref ref-type="table" rid="T1">Table 1</xref>), largely produced by microbial fermentation of complex polysaccharides (starches and fibers) in the colon (longer chain aliphatic acids with 6 to 12 carbons are considered to be medium-chain fatty acids [MCFAs]). SCFAs are absorbed into the colonic epithelium where, primarily, butyrate is consumed as a preferred fuel source by colonocytes.<sup><xref ref-type="bibr" rid="B69">69–73</xref></sup> Microbiota-produced SCFAs enter the bloodstream through the portal circulation of the host and/or the distal colon and are transported to recipient tissues where they are taken up and used in a variety of cellular responses, including the regulation of gene expression.<sup><xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B74">74</xref>,<xref ref-type="bibr" rid="B75">75</xref></sup></p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>
<bold>Chemical Structures of Fatty Acids with Two to Eight Carbon Atoms</bold>
</p>
</caption>
<!--OASIS TABLE HERE-->
<table frame="hsides" rules="groups">
<col align="left"/>
<tbody>
<tr>
<td align="left">
<inline-graphic xlink:href="inl-1.gif"></inline-graphic>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Many brain disorders are associated with imbalances in protein acetylation levels and transcriptional dysfunction.<sup><xref ref-type="bibr" rid="B76">76</xref></sup> Histone deacetylase (HDAC) inhibitors represent a promising therapeutic option to correct these deficiencies, and numerous studies using butyrate, the most potent of the SCFA HDAC inhibitors,<sup><xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B77">77</xref></sup> demonstrate the medicinal potential of butyrate in the intervention of neurodegenerative diseases and psychiatric disorders.<sup><xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B78">78–85</xref></sup></p>
<p>α-Lipoic acid [(<italic>R</italic>)-5-(1,2-dithiolan-3-yl)pentanoic acid] (ALA, <xref ref-type="fig" rid="f1">Fig. 1</xref>) is a naturally occurring 5-membered ring disulfide-substituted SCFA HDAC inhibitor<sup><xref ref-type="bibr" rid="B86">86</xref>,<xref ref-type="bibr" rid="B87">87</xref></sup> with strong antioxidant activity.<sup><xref ref-type="bibr" rid="B88">88</xref></sup> It is an essential cofactor in aerobic metabolism and is the central component forming the pyruvate dehydrogenase complex,<sup><xref ref-type="bibr" rid="B89">89</xref>,<xref ref-type="bibr" rid="B90">90</xref></sup> which functionally links glycolysis in the cytoplasm to oxidative phosphorylation (OXPHOS) in mitochondria.<sup><xref ref-type="bibr" rid="B91">91</xref></sup> ALA plays a role in microbial metabolism too.<sup><xref ref-type="bibr" rid="B92">92</xref></sup> Although ALA is present in almost all food types that we eat,<sup><xref ref-type="bibr" rid="B93">93</xref></sup> and is readily digested, absorbed, and transported to tissues, including brain,<sup><xref ref-type="bibr" rid="B94">94–96</xref></sup> the amounts available from diet are low.<sup><xref ref-type="bibr" rid="B93">93</xref></sup> Although the acquisition and use of ALA vary in different microbes, yeast, and animal cells,<sup><xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref></sup> its functions are, nonetheless, essential to the organism, and in most prokaryotic and eukaryotic microorganisms, plant and animal mitochondria, and plant plastids, ALA is enzymatically synthesized endogenously from the MCFA, octanoate.<sup><xref ref-type="bibr" rid="B97">97–99</xref></sup></p>
<fig fig-type="figure" id="f1" orientation="portrait" position="float">
<label>
<bold>FIG. 1.</bold>
</label>
<caption>
<p>Chemical structure of <italic>R</italic>-(+)-lipoic acid.</p>
</caption>
<graphic xlink:href="fig-1"></graphic>
</fig>
<p>In addition to its role in the metabolic pathways, ALA is reported in many research studies to be a potent activator of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) antioxidant response element signaling pathway that regulates the expression of genes whose protein products are involved in the detoxification and elimination of reactive oxygen species and electrophilic agents.<sup><xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B96">96</xref>,<xref ref-type="bibr" rid="B100">100–102</xref></sup> Oxidative stress has been implicated in the pathogenesis of various neurodegenerative and neuropsychiatric disorders, including depression.<sup><xref ref-type="bibr" rid="B103">103</xref>,<xref ref-type="bibr" rid="B104">104</xref></sup> Vasconcelos et al.<sup><xref ref-type="bibr" rid="B105">105</xref></sup> showed that ALA (100 mg/kg) alone or combined with clozapine reversed schizophrenia-like alterations induced by ketamine. Ketamine is a known glutamatergic <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptor antagonist that can induce psychotomimetic, perceptual, cognitive, and neuroendocrine responses in humans and in rodent models of schizophrenia.<sup><xref ref-type="bibr" rid="B106">106</xref>,<xref ref-type="bibr" rid="B107">107</xref></sup> ALA also inhibits nuclear factor kappa-B (NF-κB) activation independent of its antioxidant function. NF-κB belongs to an important group of transcription factors regulated by a kinase-mediated signaling pathway that transduces signals from the cell surface to changes in gene expression.<sup><xref ref-type="bibr" rid="B108">108</xref>,<xref ref-type="bibr" rid="B109">109</xref></sup></p>
<p>Fatty acids represent one of the body's long-term storage reservoirs and sources of fuel energy—the heart being a primary consumer.<sup><xref ref-type="bibr" rid="B110">110</xref></sup> In the presence of respiratory oxygen, fatty acids are shuttled through the mitochondrial OXPHOS complex system, where they are degraded by two carbon units at a time to shorter-chain fatty acids (and ultimately to acetyl coenzyme A), with concomitant release of water, CO<sub>2</sub>, and ATP in the process. The cellular availability of SCFAs for use in epigenetic chromatin remodeling through their ability to inhibit HDAC activity, therefore, is closely tied to mitochondrial energy production and metabolism. Since both prokaryote and eukaryote cells share common pathways for energy production, for example, the citric acid cycle,<sup><xref ref-type="bibr" rid="B75">75</xref></sup> it comes as no surprise that gut microbiota inexorably affect host–cell bioenergetics, which in turn fuels gene expression in the mitochondrial and nuclear genomes.<sup><xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B111">111</xref></sup> Over a billion years of evolutionary history have allowed our mitochondrial DNA (mtDNA) and nuclear DNA to coevolve with a high degree of genetic compatibility.<sup><xref ref-type="bibr" rid="B112">112</xref>,<xref ref-type="bibr" rid="B113">113</xref></sup> Interestingly, our microbiome and our mitogenome (mtDNA), as well as portions of our epigenome—for example, maternal silencing,<sup><xref ref-type="bibr" rid="B114">114</xref></sup> are uniquely passed to each of us from our mother.</p>
<p>Gut microbiota have a profound influence on the host immune system.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> Maternal immune activation is a shared environmental risk factor for a plethora of neuropsychiatric and neurodegenerative disorders that may or may not develop into clinical symptoms in offspring.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> Evidence from an in-depth study<sup><xref ref-type="bibr" rid="B115">115</xref></sup> of data extracted from the Danish health registry of more than 1 million children born between 1980 and 2005, focusing on cases where the mother had a viral infection with fever requiring hospitalization during the first trimester, strongly links maternal immune dysregulation with suppressed neurodevelopment and cognitive function (ASD) in their offspring.<sup><xref ref-type="bibr" rid="B116">116</xref></sup> In other epidemiological studies,<sup><xref ref-type="bibr" rid="B117">117</xref></sup> prenatal exposure to infection visibly stands out as a risk factor in schizophrenia and other neurodevelopmental abnormalities. The possibility that prenatal Zika virus infection from a mosquito reservoir is responsible for the current outbreak in Brazil of children born with microcephaly is a disturbing and frightening example.<sup><xref ref-type="bibr" rid="B118">118–121</xref></sup></p>
</sec>
<sec id="s003">
<title>Synthetic Biology</title>
<p>With a capacity to act either naturally or by manipulation, the gut microbial ecosystem is an indispensable and constituent player in the maintenance of our well-being.<sup><xref ref-type="bibr" rid="B7">7</xref></sup> Thus, in treating disease, adjusting the functional composition of the gut microbiome may help facilitate and even alter the outcome of therapeutic interventions.<sup><xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B123">123</xref></sup> Dietary sources of probiotics such as, for example, in traditional Greek yogurt, have been used since antiquity in the Mediterranean region (Mediterranean diet)<sup><xref ref-type="bibr" rid="B124">124</xref>,<xref ref-type="bibr" rid="B125">125</xref></sup> to maintain a state of wellness. However, once pathogenic dysbiosis sets in, probiotics have not proven to be remedial<sup><xref ref-type="bibr" rid="B123">123</xref>,<xref ref-type="bibr" rid="B126">126</xref>,<xref ref-type="bibr" rid="B127">127</xref></sup> and other interventional methods are being investigated. In this effort, independent work from several groups suggests that (engineered) bacteria have potential to be an effective means for delivering, enhancing, or themselves acting as therapeutic agents (“living pills”)<sup><xref ref-type="bibr" rid="B128">128</xref></sup> to treat certain diseases,<sup><xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B129">129–132</xref></sup> including psychiatric disorders,<sup><xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B133">133–136</xref></sup> and significant investments are being made to adapt a variety of commensal microbial species for remodeling the gut microbiota (ecobiotics) in disease-treating indications.<sup><xref ref-type="bibr" rid="B133">133</xref>,<xref ref-type="bibr" rid="B137">137–139</xref></sup> A similar approach aims to utilize engineered viruses to seek and selectively destroy pathogenic bacteria.<sup><xref ref-type="bibr" rid="B140">140–142</xref></sup> Drawing conclusions from a study of 11 children affected by ASD that showed improvement in communication and behavioral tests after being treated with vancomycin for 8 weeks, Mangiola et al.<sup><xref ref-type="bibr" rid="B46">46</xref></sup> speculate that modulation of gut microbiota through antibiotic treatment may influence the symptoms and expression of psychiatric disorders in general. Devkota<sup><xref ref-type="bibr" rid="B143">143</xref></sup> takes this further by underscoring a comprehensive need for more investigations into drug–microbiome interactions and the mechanisms that are involved therein.</p>
<p>Interestingly, during long stays in space, the configuration of the gut microbiome of astronauts is often significantly transformed relative to the one they had on Earth.<sup><xref ref-type="bibr" rid="B144">144–146</xref></sup> The ongoing NASA Twins Study, with Scott Kelly having recently returned from a historic 340-day mission aboard the International Space Station, may shine additional light on this subject.<sup><xref ref-type="bibr" rid="B147">147</xref></sup> Gut microbial dysregulation can alter one's immune status and cause aberrant social and cognitive behavior.<sup><xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B148">148</xref>,<xref ref-type="bibr" rid="B149">149</xref></sup> This may result in catastrophic consequences during long space flights, as for example, to Mars, if an astronaut's ability to carry out demanding tasks at a high performance and optimal level becomes severely compromised.<sup><xref ref-type="bibr" rid="B150">150</xref></sup> History shows that addressing the technological challenges space exploration presents has a constructive rippling effect on the technological advances made for a wide range of applications here on Earth. Synthetic biology<sup><xref ref-type="bibr" rid="B151">151</xref></sup> has potential to deliver robust and reliable organisms that can assist on long-duration astronaut missions.<sup><xref ref-type="bibr" rid="B152">152</xref></sup> It is anticipated that the techniques required to be developed may also be applied to engineer phage and bacteria to explore and to therapeutically modify the gut microbiome as needed.<sup><xref ref-type="bibr" rid="B153">153</xref></sup></p>
</sec>
<sec id="s004">
<title>Brain Development and Neurological Disorders</title>
<p>Aging is a leading risk factor (<xref ref-type="fig" rid="f2">Fig. 2</xref>)<sup><xref ref-type="bibr" rid="B154">154</xref></sup> in progressing to dementia.<sup><xref ref-type="bibr" rid="B155">155–159</xref></sup> Although the latest studies suggest that the prevalence of dementia may be leveling off and even decreasing in some subsets of the population,<sup><xref ref-type="bibr" rid="B160">160</xref></sup> for the foreseeable future, dementia will continue to be a major challenge for the healthcare establishment.<sup><xref ref-type="bibr" rid="B161">161</xref></sup></p>
<fig fig-type="figure" id="f2" orientation="portrait" position="float">
<label>
<bold>FIG. 2.</bold>
</label>
<caption>
<p>Meta analyzed estimates of dementia prevalence in the United States.</p>
</caption>
<graphic xlink:href="fig-2"></graphic>
</fig>
<p>The gut's evolving capacity to adapt and maintain normal microbiota, which begins at birth and continues throughout one's life, is necessary to support the metabolic activities of the brain.<sup><xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B162">162</xref></sup> This is especially so in the early childhood years through adulthood.<sup><xref ref-type="bibr" rid="B59">59</xref></sup> Studies have shown that some of the typical behavioral and physiological abnormalities associated with neurodevelopmental disorders, including autism<sup><xref ref-type="bibr" rid="B43">43–45</xref>,<xref ref-type="bibr" rid="B163">163–165</xref></sup> and schizophrenia,<sup><xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B47">47–49</xref></sup> can be modulated by reconfiguring the gut microbiome composition.<sup><xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B166">166</xref></sup></p>
<p>Acetate, propionate, and butyrate comprise the majority of SCFAs produced in the gut by microbial fermentation.<sup><xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B69">69</xref></sup> Propionate and butyrate can modulate brain functioning, principally appetite and energy homeostasis, through regulation of neuropeptide production.<sup><xref ref-type="bibr" rid="B167">167</xref></sup> Butyrate is mostly absorbed by the colonic epithelium, whereas acetate and propionate are passed into the portal circulation.<sup><xref ref-type="bibr" rid="B168">168–170</xref></sup> In gut dysbiosis, the constitutional spectrum of SCFAs varies substantially from the host's natural healthy balance,<sup><xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B171">171</xref></sup> and higher than normal levels of PPA have been linked to deleterious effects on brain function<sup><xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B172">172–179</xref></sup> in autistic children.<sup><xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B174">174</xref></sup> Given these findings, and the fact that PPA is widely used as a food preservative,<sup><xref ref-type="bibr" rid="B180">180</xref></sup> there may be cause for some concern.</p>
<p>Idiopathic late-onset dementia (ILOD) is characterized by a series of declining daily functional competences, most often involving memory, reasoning, and sociobehavioral abilities, in the elderly.<sup><xref ref-type="bibr" rid="B157">157</xref>,<xref ref-type="bibr" rid="B161">161</xref></sup> Dementia encompasses a myriad of clinical symptoms typically associated with discrete neurological disorders such as Alzheimer and Parkinson diseases, hippocampal sclerosis of aging, and Lewy body and frontotemporal dementias being the more notable ones, but not collectively manifested by any one of them. Cellular processes depend on the energy supplied by their mitochondria, and dysfunctional mitochondria can lead to an unsustainable cellular bioenergetics deficit that is detrimental to the cell's function and survival.<sup><xref ref-type="bibr" rid="B181">181</xref></sup> In brain cells, even a small energy deficit, which is a common occurrence during the aging process, can reduce synaptic neurotransmitter release and adversely affect synaptic function.<sup><xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B101">101</xref></sup> Maintaining a healthy gut microbiota state is necessary to support the metabolic activities of the brain,<sup><xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B162">162</xref></sup> and Mattson<sup><xref ref-type="bibr" rid="B157">157</xref></sup> and Bourassa et al.<sup><xref ref-type="bibr" rid="B85">85</xref></sup> posit that some of the common pathologies leading to ILOD and other brain disorders may be amenable to therapeutic modification by diet and lifestyle changes. For example, exercise, yoga, and meditation are lifestyle activities known to improve brain blood flow—which, presumably, can enhance perfusion of the brain with micronutrients absorbed by the gut<sup><xref ref-type="bibr" rid="B182">182</xref></sup>—and are increasingly being incorporated in treatments for depression and other mental disturbances.<sup><xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B127">127</xref>,<xref ref-type="bibr" rid="B183">183–185</xref></sup></p>
<p>At the other end of the age spectrum, the correlation between impaired intellectual development and a prolonged state of malnutrition in infants and young children is inescapable.<sup><xref ref-type="bibr" rid="B186">186–189</xref></sup> Recent studies have demonstrated that the normal pattern of gut microbiota assembly is disrupted in malnourished children.<sup><xref ref-type="bibr" rid="B162">162</xref>,<xref ref-type="bibr" rid="B187">187</xref></sup> To maximize the therapeutic benefit of diet and dietary supplements, preclinical evidence suggests that a healthy microbiome in these children may need to be configured as well.<sup><xref ref-type="bibr" rid="B190">190</xref>,<xref ref-type="bibr" rid="B191">191</xref></sup></p>
</sec>
<sec id="s005">
<title>Concluding Remarks</title>
<p>The importance of physical activity coupled with a balanced and healthy diet in the maintenance of our well-being has been recognized since antiquity. However, it is only recently that characterization of the host–microbiome intermetabolic and crosstalk pathways has come to the forefront for study in therapeutic design and treatments.<sup><xref ref-type="bibr" rid="B68">68</xref>,<xref ref-type="bibr" rid="B192">192</xref></sup> As reviewed in this report, synthetic biology has potential to develop microorganisms for correcting pathogenic dysbiosis, but this has yet to be proven. (For additional examples of the latest approaches to manipulating the microbiota, including illustrative figures, see Ash and Mueller,<sup><xref ref-type="bibr" rid="B193">193</xref></sup> and articles cited therein.) In contrast, the development and use of small molecule drugs have a long and successful history in the clinical treatment of diseases. Small molecule HDAC inhibitors are already used in the clinic to treat cancer and hematological disorders,<sup><xref ref-type="bibr" rid="B77">77</xref></sup> and preclinical research with SCFA HDAC inhibitors demonstrates significant potential in epigenetic treatment of neurological conditions.<sup><xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B101">101</xref></sup> Epigenetic regulation of host–microbiota interactions by utilizing epigenomic-targeting drugs has been suggested by Alenghat and Artis.<sup><xref ref-type="bibr" rid="B74">74</xref></sup></p>
<p>The mouth, being an extension of the digestive tract, presents a readily accessible diagnostic site for the early detection of potential unhealthy pathogens resident in the gut. Salivanomics is a rapidly emerging tool in the arsenal of salivary diagnostics.<sup><xref ref-type="bibr" rid="B194">194</xref></sup> Collecting saliva or swabbing the inside cheek of the mouth is noninterventional, making it a highly attractive diagnostic procedure, particularly for infants and young children. It is not unlikely that regular visits to your dentist may soon be as important to your gut as it is to your oral hygiene, white teeth, and a nice smile.</p>
</sec>
</body>
<back>
<sec id="s006" sec-type="ack">
<title>Acknowledgments</title>
<p>We thank the MitoCure Foundation for their generous financial support, and Drs. Carl A. Pinkert (The University of Alabama, Tuscaloosa, AL), Michael H. Irwin (Auburn University, Auburn, AL), Robert J. Zamboni (McGill University, Montreal, QC, Canada), and Susan P. Perrine (Boston University School of Medicine) for their invaluable advice and helpful discussions in the preparation of this article.</p>
</sec>
<sec id="s007">
<title>Authors’ Contributions</title>
<p>The article was written through contributions of all authors. All authors have given approval to the final version of the article.</p>
</sec>
<sec id="s008" sec-type="COI-statement">
<title>Author Disclosure Statement</title>
<p>K.S. owns shares in PhenoMatriX. W.H.M. and K.S. have collaborated in the past on cancer projects as part of a formal agreement between SRI International and PhenoMatriX. No competing financial interests exist.</p>
</sec>
<ref-list content-type="parsed">
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietert</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dietert</surname><given-names>R</given-names></name></person-group>
<article-title>The sum of our parts</article-title>. <source/>Scientist. <year>2015</year>;<volume>29</volume>:<fpage>44</fpage>–<lpage>49</lpage></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghannoum</surname><given-names>M</given-names></name></person-group>
<article-title>The mycobiome</article-title>. <source/>Scientist. <year>2016</year>;<volume>30</volume>:<fpage>32</fpage>–<lpage>37</lpage></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fond</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boukouaci</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The “psychomicrobiotic”: targeting microbiota in major psychiatric disorders: a systematic review</article-title>. <source/>Pathol Biol. <year>2015</year>;<volume>63</volume>:<fpage>35</fpage>–<lpage>42</lpage><pub-id pub-id-type="pmid">25468489</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Sender</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Milo</surname><given-names>R</given-names></name></person-group>
<article-title>Revised estimates for the number of human and bacteria cells in the body</article-title>. <source/>BioRxiv.
<year>2016</year> [Epub ahead of print]; DOI: <uri xlink:href="http://dx.doi.org/10.1101/036103" xlink:type="simple">http://dx.doi.org/10.1101/036103</uri></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blekhman</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goodrich</surname><given-names>JK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Host genetic variation impacts microbiome composition across human body sites</article-title>. <source/>Genome Biol. <year>2015</year>;<volume>16</volume>:<fpage>191</fpage><pub-id pub-id-type="pmid">26374288</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohórquez</surname><given-names>DV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liddle</surname><given-names>RA</given-names></name></person-group>
<article-title>The gut connectome: making sense of what you eat</article-title>. <source/>J Clin Invest. <year>2015</year>;<volume>125</volume>:<fpage>888</fpage>–<lpage>890</lpage><pub-id pub-id-type="pmid">25729849</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppel</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Balskus</surname><given-names>EP</given-names></name></person-group>
<article-title>Exploring and understanding the biochemical diversity of the human microbiota</article-title>. <source/>Cell Chem Biol. <year>2016</year>;<volume>23</volume>:<fpage>18</fpage>–<lpage>30</lpage><pub-id pub-id-type="pmid">26933733</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sudo</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Mood and gut feelings</article-title>. <source/>Brain Behav Immun. <year>2010</year>;<volume>24</volume>:<fpage>9</fpage>–<lpage>16</lpage><pub-id pub-id-type="pmid">19481599</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natarajan</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pluznick</surname><given-names>JL</given-names></name></person-group>
<article-title>From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology</article-title>. <source/>Am J Physiol Cell Physiol. <year>2014</year>;<volume>307</volume>:<fpage>C979</fpage>–<lpage>C985</lpage><pub-id pub-id-type="pmid">25273884</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietert</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dietert</surname><given-names>J</given-names></name></person-group>
<article-title>The microbiome and sustainable healthcare</article-title>. <source/>Healthcare. <year>2015</year>;<volume>3</volume>:<fpage>100</fpage>–<lpage>129</lpage><pub-id pub-id-type="pmid">27417751</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caesar</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tremaroli</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kovatcheva-Datchary</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling</article-title>. <source/>Cell Metabol. <year>2015</year>;<volume>22</volume>:<fpage>1</fpage>–<lpage>11</lpage></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hand</surname><given-names>TW</given-names></name></person-group>
<article-title>Role of the microbiota in immunity and inflammation</article-title>. <source/>Cell. <year>2014</year>;<volume>157</volume>:<fpage>121</fpage>–<lpage>141</lpage><pub-id pub-id-type="pmid">24679531</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>ML</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McAllister</surname><given-names>AK</given-names></name></person-group>
<article-title>Immune mediators in the brain and peripheral tissues in autism spectrum disorder</article-title>. <source/>Nat Rev Neurosci. <year>2015</year>;<volume>16</volume>:<fpage>469</fpage>–<lpage>486</lpage><pub-id pub-id-type="pmid">26189694</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grogan</surname><given-names>D</given-names></name></person-group>
<article-title>The microbes within</article-title>. <source/>Nature. <year>2015</year>;<volume>518</volume>:<fpage>S2</fpage><pub-id pub-id-type="pmid">25715277</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäckhed</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roswall</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Dynamics and stabilization of the human gut microbiome during the first year of life</article-title>. <source/>Cell Host Microbe. <year>2015</year>;<volume>17</volume>:<fpage>690</fpage>–<lpage>703</lpage><pub-id pub-id-type="pmid">25974306</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debnath</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Venkatasubramanian</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Berk</surname><given-names>M</given-names></name></person-group>
<article-title>Fetal programming of schizophrenia: select mechanisms</article-title>. <source/>Neurosci Biobehav Rev. <year>2015</year>;<volume>49</volume>:<fpage>90</fpage>–<lpage>104</lpage><pub-id pub-id-type="pmid">25496904</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group>
<article-title>Asthma: undoing millions of years of coevolution in early life?</article-title>
<source/>Sci Transl Med. <year>2015</year>;<volume>7</volume>:<fpage>307fs39</fpage></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Opstal</surname><given-names>EJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bordenstein</surname><given-names>SR</given-names></name></person-group>
<article-title>Rethinking heritability of the microbiome</article-title>. <source/>Science.
<year>2015</year>;<volume>349</volume>:<fpage>1172</fpage>–<lpage>1173</lpage><pub-id pub-id-type="pmid">26359393</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>De Jesus-Laboy</surname><given-names>KM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shen</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer</article-title>. <source/>Nat Med. <year>2016</year>;<volume>22</volume>:<fpage>250</fpage>–<lpage>253</lpage><pub-id pub-id-type="pmid">26828196</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez de Agüero</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ganal-Vonarburg</surname><given-names>SC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fuhrer</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The maternal microbiota drives early postnatal innate immune development</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>1296</fpage>–<lpage>1302</lpage><pub-id pub-id-type="pmid">26989247</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Asmakh</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hedin</surname><given-names>L</given-names></name></person-group>
<article-title>Microbiota and the control of blood-tissue barriers</article-title>. <source/>Tissue Barriers. <year>2015</year>;<volume>3</volume>:<fpage>e10396</fpage></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenney</surname><given-names>PT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group>
<article-title>2015. From hype to hope: the gut microbiota in enteric infectious disease</article-title>. <source/>Cell
<volume>163</volume>:<fpage>1326</fpage>–<lpage>1332</lpage><pub-id pub-id-type="pmid">26638069</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharschmidt</surname><given-names>TC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vasquez</surname><given-names>KS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Truong</surname><given-names>H-A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes</article-title>. <source/>Immunity. <year>2015</year>;<volume>43</volume>:<fpage>1011</fpage>–<lpage>1021</lpage><pub-id pub-id-type="pmid">26588783</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roberts</surname><given-names>AB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Buffa</surname><given-names>JA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis</article-title>. <source/>Cell. <year>2015</year>;<volume>163</volume>:<fpage>1585</fpage>–<lpage>1595</lpage><pub-id pub-id-type="pmid">26687352</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Corwin</surname><given-names>EJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brennan</surname><given-names>PA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The infant microbiome. Implications for infant health and neurocognitive development</article-title>. <source/>Nursing Res. <year>2016</year>;<volume>65</volume>:<fpage>76</fpage>–<lpage>88</lpage></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moos</surname><given-names>WH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maneta</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pinkert</surname><given-names>CA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epigenetic treatment of neuropsychiatric disorders: autism and schizophrenia</article-title>. <source/>Drug Dev Res. <year>2016</year>;<volume>77</volume>:<fpage>53</fpage>–<lpage>72</lpage><pub-id pub-id-type="pmid">26899191</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakir</surname><given-names>R</given-names></name></person-group>
<article-title>Neurodegenerative noncommunicable diseases (neurology NCDs). Where are we now?</article-title>
<source/>J Neurol Sci. <year>2015</year>;<volume>356</volume>:<fpage>1</fpage>–<lpage>2</lpage><pub-id pub-id-type="pmid">26165774</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberberg</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Anand</surname><given-names>NP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Michels</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Brain and other nervous system disorders across the lifespan—global challenges and opportunities</article-title>. <source/>Nature. <year>2015</year>;<volume>527</volume>:<fpage>S151</fpage>–<lpage>S154</lpage><pub-id pub-id-type="pmid">26580320</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borre</surname><given-names>YE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Keeffe</surname><given-names>GW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Microbiota and neurodevelopmental windows: implications for brain disorders</article-title>. <source/>Trends Mol Med. <year>2014</year>;<volume>20</volume>:<fpage>509</fpage>–<lpage>518</lpage><pub-id pub-id-type="pmid">24956966</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Theije</surname><given-names>CGM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bavelaar</surname><given-names>BM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>da Silva</surname><given-names>SL</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Food allergy and food-based therapies in neurodevelopmental disorders</article-title>. <source/>Pediatr Allergy Immunol. <year>2014</year>;<volume>25</volume>:<fpage>218</fpage>–<lpage>226</lpage><pub-id pub-id-type="pmid">24236934</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>EA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Knight</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mazmanian</surname><given-names>SK</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut microbes and the brain: paradigm shift in neuroscience</article-title>. <source/>J Neurosci. <year>2014</year>;<volume>34</volume>:<fpage>15490</fpage>–<lpage>15496</lpage><pub-id pub-id-type="pmid">25392516</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stilling</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>Microbial genes, brain &amp; behaviour—epigenetic regulation of the gut–brain axis</article-title>. <source/>Genes Brain Behav. <year>2014</year>;<volume>13</volume>:<fpage>69</fpage>–<lpage>86</lpage><pub-id pub-id-type="pmid">24286462</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bienenstock</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kunze</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>P</given-names></name></person-group>
<article-title>Microbiota and the gut–brain axis</article-title>. <source/>Nutr Rev. <year>2015</year>;<volume>73</volume>(<issue>S1</issue>):<fpage>28</fpage>–<lpage>31</lpage><pub-id pub-id-type="pmid">26175487</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Dash</surname><given-names>SR</given-names></name></person-group>
<article-title>The microbiome and brain health: what's the connection? Medscape, March 24,</article-title>
<year>2015</year> Accessed <date-in-citation><month>3</month><day>21</day>, <year>2016</year></date-in-citation>, <uri xlink:href="http://www.medscape.com/viewarticle/841748" xlink:type="simple">http://www.medscape.com/viewarticle/841748</uri></mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stilling</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stanton</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Collective unconscious: how gut microbes shape human behavior</article-title>. <source/>J Psychiatr Res. <year>2015</year>;<volume>63</volume>:<fpage>1</fpage>–<lpage>9</lpage><pub-id pub-id-type="pmid">25772005</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>BJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rucklidge</surname><given-names>JJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Romijn</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The emerging field of nutritional mental health: inflammation, the microbiome, oxidative stress, and mitochondrial function</article-title>. <source/>Clin Psychol Sci. <year>2015</year>;<volume>3</volume>:<fpage>964</fpage>–<lpage>980</lpage></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zaghouani</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Niklas</surname><given-names>V</given-names></name></person-group>
<article-title>Gut microbiota, the immune system, and diet influence the neonatal gut–brain axis</article-title>. <source/>Pediatr Res. <year>2015</year>;<volume>77</volume>:<fpage>127</fpage>–<lpage>135</lpage><pub-id pub-id-type="pmid">25303278</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>GP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>
<article-title>Gut biogeography of the bacterial microbiota</article-title>. <source/>Nat Rev Microbiol. <year>2016</year>;<volume>14</volume>:<fpage>20</fpage>–<lpage>32</lpage><pub-id pub-id-type="pmid">26499895</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>EY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McBride</surname><given-names>SW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hsien</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>. <source/>Cell. <year>2013</year>;<volume>155</volume>:<fpage>1451</fpage>–<lpage>1463</lpage><pub-id pub-id-type="pmid">24315484</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraneveld</surname><given-names>AD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Theije</surname><given-names>CGM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>van Heesch</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The neuro-immune axis: prospect for novel treatments for mental disorders</article-title>. <source/>Basic Clin Pharmacol Toxicol. <year>2014</year>;<volume>114</volume>:<fpage>128</fpage>–<lpage>136</lpage><pub-id pub-id-type="pmid">24118847</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buie</surname><given-names>T</given-names></name></person-group>
<article-title>Potential etiologic factors of microbiome disruption in autism</article-title>. <source/>Clin Ther. <year>2015</year>;<volume>37</volume>:<fpage>976</fpage>–<lpage>983</lpage><pub-id pub-id-type="pmid">26046240</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carding</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Verbeke</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vipond</surname><given-names>DT</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Dysbiosis of the gut microbiota in disease</article-title>. <source/>Microb Ecol Health Dis. <year>2015</year>;<volume>26</volume>:<fpage>26191</fpage><pub-id pub-id-type="pmid">25651997</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>RE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rose</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Slattery</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome</article-title>. <source/>Microb Ecol Health Dis. <year>2015</year>;<volume>26</volume>:<fpage>27458</fpage><pub-id pub-id-type="pmid">25956238</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cao</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name></person-group>
<article-title>Modulation of gut microbiota–brain axis by probiotics, prebiotics, and diet</article-title>. <source/>J Agric Food Chem. <year>2015</year>;<volume>63</volume>:<fpage>7885</fpage>–<lpage>7895</lpage><pub-id pub-id-type="pmid">26306709</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>BL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Saier</surname><given-names>MH</given-names></name></person-group>
<article-title>Autism and our intestinal microbiota</article-title>. <source/>J Mol Microbiol Biotechnol. <year>2015</year>;<volume>25</volume>:<fpage>51</fpage>–<lpage>55</lpage><pub-id pub-id-type="pmid">25792275</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangiola</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ianiro</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Franceschi</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut microbiota in autism and mood disorders</article-title>. <source/>World J Gastroenterol. <year>2016</year>;<volume>22</volume>: <fpage>361</fpage>–<lpage>368</lpage><pub-id pub-id-type="pmid">26755882</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borre</surname><given-names>YE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>Genomics of schizophrenia: time to consider the gut microbiome?</article-title>
<source/>Mol Psychiatry. <year>2014</year>;<volume>19</volume>:<fpage>1252</fpage>–<lpage>1257</lpage><pub-id pub-id-type="pmid">25288135</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemani</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghomi</surname><given-names>RH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McCormick</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Schizophrenia and the gut–brain axis</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry. <year>2015</year>;<volume>56</volume>:<fpage>155</fpage>–<lpage>160</lpage><pub-id pub-id-type="pmid">25240858</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Severance</surname><given-names>EG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Prandovszky</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Castiglione</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gastroenterology issues in schizophrenia: why the gut matters</article-title>. <source/>Curr Psychiatry Rep. <year>2015</year>;<volume>17</volume>:<fpage>27</fpage><pub-id pub-id-type="pmid">25773227</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadman</surname><given-names>KK</given-names></name></person-group>
<article-title>Making progress in autism drug discovery</article-title>. <source/>Expert Opin Drug Discov. <year>2014</year>;<volume>9</volume>:<fpage>1389</fpage>–<lpage>1391</lpage><pub-id pub-id-type="pmid">25251213</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekar</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bialas</surname><given-names>AR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Rivera</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Schizophrenia risk from complex variation of complement component 4</article-title>. <source/>Nature. <year>2016</year>;<volume>530</volume>:<fpage>177</fpage>–<lpage>183</lpage><pub-id pub-id-type="pmid">26814963</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muir</surname><given-names>WJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McKechanie</surname><given-names>AG</given-names></name></person-group>
<article-title>Can epigenetics help in the discovery of therapeutics for psychiatric disorders, especially schizophrenia?</article-title>
<source/>Expert Opin Drug Discov. <year>2009</year>;<volume>4</volume>:<fpage>621</fpage>–<lpage>627</lpage><pub-id pub-id-type="pmid">23489155</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosia</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pigoni</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cavallaro</surname><given-names>R</given-names></name></person-group>
<article-title>Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back</article-title>. <source/>Expert Opin Drug Discov. <year>2015</year>;<volume>10</volume>:<fpage>125</fpage>–<lpage>139</lpage><pub-id pub-id-type="pmid">25345474</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinde</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lewis</surname><given-names>ZT</given-names></name></person-group>
<article-title>Mother's littlest helpers. Breastmilk nourishes the microbes colonizing the neonatal intestinal tract</article-title>. <source/>Science. <year>2015</year>;<volume>348</volume>:<fpage>1427</fpage>–<lpage>1428</lpage><pub-id pub-id-type="pmid">26113704</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meadow</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Altrichter</surname><given-names>AE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bateman</surname><given-names>AC</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Humans differ in their personal microbial cloud</article-title>. <source/>PeerJ. <year>2015</year>;<volume>3</volume>:<fpage>e1258</fpage><pub-id pub-id-type="pmid">26417541</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeevi</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Korem</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zmora</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Personalized nutrition by prediction of glycemic responses</article-title>. <source/>Cell. <year>2015</year>;<volume>163</volume>:<fpage>1079</fpage>–<lpage>1094</lpage><pub-id pub-id-type="pmid">26590418</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuker</surname><given-names>CS</given-names></name></person-group>
<article-title>Food for the brain</article-title>. <source/>Cell. <year>2015</year>;<volume>161</volume>:<fpage>9</fpage>–<lpage>11</lpage><pub-id pub-id-type="pmid">25815979</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabouridis</surname><given-names>PS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pachnis</surname><given-names>V</given-names></name></person-group>
<article-title>Emerging roles of gut microbiota and the immune system in the development of the enteric nervous system</article-title>. <source/>J Clin Invest. <year>2015</year>;<volume>125</volume>:<fpage>956</fpage>–<lpage>964</lpage><pub-id pub-id-type="pmid">25729852</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyal</surname><given-names>MS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Venkatesh</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Milbrandt</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Feeding the brain and nurturing the mind: linking nutrition and the gut microbiota to brain development</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2015</year>;<volume>112</volume>:<fpage>14105</fpage>–<lpage>14112</lpage><pub-id pub-id-type="pmid">26578751</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>AWF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kersten</surname><given-names>S</given-names></name></person-group>
<article-title>The role of the gut microbiota in metabolic health</article-title>. <source/>FASEB J. <year>2015</year>;<volume>29</volume>:<fpage>3111</fpage>–<lpage>3123</lpage><pub-id pub-id-type="pmid">25921831</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledford</surname><given-names>H</given-names></name></person-group>
<article-title>The genome unwrapped</article-title>. <source/>Nature. <year>2015</year>;<volume>528</volume>:<fpage>S12</fpage>–<lpage>S13</lpage><pub-id pub-id-type="pmid">26630592</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name></person-group>
<article-title>Influence of bacteria on epigenetic gene control</article-title>. <source/>Cell Mol Life Sci. <year>2014</year>;<volume>71</volume>:<fpage>1045</fpage>–<lpage>1054</lpage><pub-id pub-id-type="pmid">24132510</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefano</surname><given-names>GB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kream</surname><given-names>RM</given-names></name></person-group>
<article-title>Dysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review)</article-title>. <source/>Int J Mol Med. <year>2016</year>;<volume>37</volume>:<fpage>547</fpage>–<lpage>555</lpage><pub-id pub-id-type="pmid">26821064</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vadder</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kovatcheva-Datchary</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits</article-title>. <source/>Cell. <year>2014</year>;<volume>156</volume>:<fpage>84</fpage>–<lpage>96</lpage><pub-id pub-id-type="pmid">24412651</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jandhyala</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Talukdar</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Subramanyam</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Role of the normal gut microbiota</article-title>. <source/>World J Gastroenterol. <year>2015</year>;<volume>21</volume>:<fpage>8787</fpage>–<lpage>8803</lpage><pub-id pub-id-type="pmid">26269668</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Psichas</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reimann</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gribble</surname><given-names>FM</given-names></name></person-group>
<article-title>Gut chemosensing mechanisms</article-title>. <source/>J Clin Invest. <year>2015</year>;<volume>125</volume>:<fpage>908</fpage>–<lpage>917</lpage><pub-id pub-id-type="pmid">25664852</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheperjans</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aho</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pereira</surname><given-names>PAB</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut microbiota are related to Parkinson's disease and clinical phenotype</article-title>. <source/>Mov Disord. <year>2015</year>;<volume>30</volume>:<fpage>350</fpage>–<lpage>358</lpage><pub-id pub-id-type="pmid">25476529</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saint-Georges-Chaumet</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Edeas</surname><given-names>M</given-names></name></person-group>
<article-title>Microbiota–mitochondria inter-talk: consequence for microbiota–host interaction</article-title>. <source/>FEMS Pathog Dis. <year>2016</year>;<volume>74</volume>:<fpage>ftv096</fpage></mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donohoe</surname><given-names>DR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garge</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon</article-title>. <source/>Cell Metab. <year>2011</year>;<volume>13</volume>:<fpage>517</fpage>–<lpage>526</lpage><pub-id pub-id-type="pmid">21531334</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donohoe</surname><given-names>DR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Collins</surname><given-names>LB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wali</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation</article-title>. <source/>Mol Cell. <year>2012</year>;<volume>48</volume>:<fpage>612</fpage>–<lpage>626</lpage><pub-id pub-id-type="pmid">23063526</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alden</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name></person-group>
<article-title>Pathways and functions of gut microbiota metabolism impacting host physiology</article-title>. <source/>Curr Opin Biotechnol. <year>2015</year>;<volume>36</volume>:<fpage>137</fpage>–<lpage>145</lpage><pub-id pub-id-type="pmid">26340103</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasquez-Manoff</surname><given-names>M</given-names></name></person-group>
<article-title>Gut microbiome: the peacekeepers</article-title>. <source/>Nature. <year>2015</year>;<volume>518</volume>:<fpage>S3</fpage>-<lpage>S11</lpage><pub-id pub-id-type="pmid">25715278</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Raman</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ambalam</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Doble</surname><given-names>M</given-names></name></person-group>
<article-title>Short-chain fatty acids</article-title>. In: <source/>Probiotics and Bioactive Carbohydrates in Colon Cancer Management. <publisher-name>Springer</publisher-name>: <publisher-name>New Delhi, India</publisher-name>; pp. <fpage>97</fpage>–<lpage>115</lpage>; <year>2016</year></mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alenghat</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Artis</surname><given-names>D</given-names></name></person-group>
<article-title>Epigenomic regulation of host–microbiota interactions</article-title>. <source/>Trends Immunol. <year>2014</year>;<volume>35</volume>:<fpage>518</fpage>–<lpage>525</lpage><pub-id pub-id-type="pmid">25443494</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>DF</given-names></name></person-group>
<article-title>Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders</article-title>. <source/>Microb Ecol Health Dis. <year>2015</year>;<volume>26</volume>:<fpage>28177</fpage><pub-id pub-id-type="pmid">26031685</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>D-M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leng</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Marinova</surname><given-names>Z</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Multiple roles of HDAC inhibition in neurodegenerative conditions</article-title>. <source/>Trends Neurosci. <year>2009</year>;<volume>32</volume>:<fpage>591</fpage>–<lpage>601</lpage><pub-id pub-id-type="pmid">19775759</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steliou</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boosalis</surname><given-names>MS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perrine</surname><given-names>SP</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Butyrate histone deacetylase inhibitors</article-title>. <source/>BioRes Open Access. <year>2012</year>;<volume>1</volume>:<fpage>192</fpage>–<lpage>198</lpage><pub-id pub-id-type="pmid">23514803</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>EA</given-names></name></person-group>
<article-title>Focal nature of neurological disorders necessitates isotype-selective histone deacetylase (HDAC) inhibitors</article-title>. <source/>Mol Neurobiol. <year>2009</year>;<volume>40</volume>:<fpage>33</fpage>–<lpage>45</lpage><pub-id pub-id-type="pmid">19396637</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayson</surname><given-names>DR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kundakovic</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sharma</surname><given-names>RP</given-names></name></person-group>
<article-title>Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?</article-title>
<source/>Mol Pharmacol. <year>2010</year>;<volume>77</volume>:<fpage>126</fpage>–<lpage>135</lpage><pub-id pub-id-type="pmid">19917878</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canani</surname><given-names>RB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Di Costanzo</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leone</surname><given-names>L</given-names></name></person-group>
<article-title>The epigenetic effects of butyrate: potential therapeutic implications for clinical practice</article-title>. <source/>Clin Epigenet. <year>2012</year>;<volume>4</volume>:<fpage>4</fpage></mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenstock</surname><given-names>TR</given-names></name></person-group>
<article-title>Lysine (K)-deacetylase inhibitors: the real next step to neuropsychiatric and neurodegenerative disorders?</article-title>
<source/>Cell Biol. <year>2013</year>;<volume>2</volume>:<fpage>a8</fpage></mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szyf</surname><given-names>M</given-names></name></person-group>
<article-title>Prospects for the development of epigenetic drugs for CNS conditions</article-title>. <source/>Nat Rev Drug Discov. <year>2015</year>;<volume>14</volume>:<fpage>461</fpage>–<lpage>474</lpage><pub-id pub-id-type="pmid">26000723</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizcarra</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilson-Perez</surname><given-names>HE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Espay</surname><given-names>AJ</given-names></name></person-group>
<article-title>The power in numbers: gut microbiota in Parkinson's disease</article-title>. <source/>Mov Disord. <year>2015</year>;<volume>30</volume>:<fpage>296</fpage>–<lpage>298</lpage><pub-id pub-id-type="pmid">25545262</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volmar</surname><given-names>C-H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wahlestedt</surname><given-names>C</given-names></name></person-group>
<article-title>Histone deacetylases (HDACs) and brain function</article-title>. <source/>Neuroepigenetics. <year>2015</year>;<volume>1</volume>:<fpage>20</fpage>–<lpage>27</lpage></mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourassa</surname><given-names>MW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alim</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bultman</surname><given-names>SJ</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health?</article-title>
<source/>Neurosci Lett.
<year>2015</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1016/j.neulet.2016.02.009</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Mark</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Steliou</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>α-Lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines</article-title>. <source/>J Cell Physiol. <year>2003</year>;<volume>194</volume>:<fpage>325</fpage>–<lpage>340</lpage><pub-id pub-id-type="pmid">12548552</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>SA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barnett</surname><given-names>MPG</given-names></name></person-group>
<article-title>The role of dietary histone deacetylases (HDACs) inhibitors in health and disease</article-title>. <source/>Nutrients. <year>2014</year>;<volume>6</volume>:<fpage>4273</fpage>–<lpage>4301</lpage><pub-id pub-id-type="pmid">25322459</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochette</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghibu</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Richard</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Direct and indirect antioxidant properties of alpha-lipoic acid and therapeutic potential</article-title>. <source/>Mol Nutr Food Res. <year>2013</year>;<volume>57</volume>:<fpage>114</fpage>–<lpage>125</lpage><pub-id pub-id-type="pmid">23293044</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname><given-names>VCJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Houten</surname><given-names>SM</given-names></name></person-group>
<article-title>A mitochondrial expatriate: nuclear pyruvate dehydrogenase</article-title>. <source/>Cell. <year>2014</year>;<volume>158</volume>:<fpage>9</fpage>–<lpage>10</lpage><pub-id pub-id-type="pmid">24995972</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutendra</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kinnaird</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dromparis</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation</article-title>. <source/>Cell. <year>2014</year>;<volume>158</volume>:<fpage>84</fpage>–<lpage>97</lpage><pub-id pub-id-type="pmid">24995980</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayr</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feichtinger</surname><given-names>RG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tort</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Lipoic acid biosynthesis defects</article-title>. <source/>J Inherit Metab Dis. <year>2014</year>
<volume>37</volume>:<fpage>553</fpage>–<lpage>563</lpage><pub-id pub-id-type="pmid">24777537</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullah</surname><given-names>MW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Khattak</surname><given-names>WA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ul-Islam</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Metabolic engineering of synthetic cell-free systems: strategies and applications</article-title>. <source/>Biochem Eng J. <year>2016</year>;<volume>105</volume>:<fpage>391</fpage>–<lpage>405</lpage></mixed-citation>
</ref>
<ref id="B93">
<label>93</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name></person-group>
<article-title>Synthetic bioactive substances</article-title>. In:<source/>Handbook of Food Chemistry. <person-group person-group-type="editor"><name><surname>Cheung</surname><given-names>PCK</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Mehta</surname><given-names>BM</given-names></name></person-group>, (eds.) <publisher-name>Springer-Verlag</publisher-name>: <publisher-loc>Berlin, Germany</publisher-loc>; pp. <fpage>1</fpage>–<lpage>20</lpage>; <year>2015</year> (ISBN: 978–3-642–41609-5)</mixed-citation>
</ref>
<ref id="B94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Smith</surname><given-names>AR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fischer</surname><given-names>SJ</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects</article-title>. <source/>Altern Med Rev. <year>2007</year>;<volume>12</volume>:<fpage>343</fpage>–<lpage>351</lpage><pub-id pub-id-type="pmid">18069903</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papanas</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>D</given-names></name></person-group>
<article-title>Efficacy of α-lipoic acid in diabetic retinopathy</article-title>. <source/>Expert Opin Pharmacother. <year>2015</year>;<volume>15</volume>:<fpage>2721</fpage>–<lpage>2731</lpage><pub-id pub-id-type="pmid">25381809</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochette</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghibu</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Muresan</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes</article-title>. <source/>Can J Physiol Pharmacol. <year>2015</year>;<volume>93</volume>:<fpage>1021</fpage>–<lpage>1027</lpage><pub-id pub-id-type="pmid">26406389</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spalding</surname><given-names>MD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sean</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Prigge</surname><given-names>ST</given-names></name></person-group>
<article-title>Lipoic acid metabolism in microbial pathogens</article-title>. <source/>Microbiol Mol Biol Rev. <year>2010</year>;<volume>74</volume>:<fpage>200</fpage>–<lpage>228</lpage><pub-id pub-id-type="pmid">20508247</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Luo</surname><given-names>Q</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gao</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A new regulatory mechanism for bacterial lipoic acid synthesis</article-title>. <source/>Microbiologyopen. <year>2015</year>;<volume>4</volume>:<fpage>282</fpage>–<lpage>300</lpage></mixed-citation>
</ref>
<ref id="B99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pashaj</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xia</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moreau</surname><given-names>R</given-names></name></person-group>
<article-title>α-Lipoic acid as a triglyceride-lowering nutraceutical</article-title>. <source/>Can J Physiol Pharmacol. <year>2015</year>;<volume>93</volume>:<fpage>1029</fpage>–<lpage>1041</lpage><pub-id pub-id-type="pmid">26235242</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dörsam</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fahrer</surname><given-names>J</given-names></name></person-group>
<article-title>The disulfide compound α-lipoic acid and its derivatives: a novel class of anticancer agents targeting mitochondria</article-title>. <source/>Cancer Lett. <year>2016</year>;<volume>371</volume>:<fpage>12</fpage>–<lpage>19</lpage><pub-id pub-id-type="pmid">26604131</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>MH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moos</surname><given-names>WH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faller</surname><given-names>DV</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epigenetic treatment of neurodegenerative disorders: Alzheimer and Parkinson diseases</article-title>. <source/>Drug Dev Res. <year>2016</year>;<volume>77</volume>:<fpage>109</fpage>–<lpage>123</lpage><pub-id pub-id-type="pmid">26899010</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>KN</given-names></name></person-group>
<article-title>Simultaneous activation of Nrf2 and elevation of dietary and endogenous antioxidant chemicals for cancer prevention in humans</article-title>. <source/>J Am Coll Nutr. <year>2016</year>;<volume>35</volume>:<fpage>175</fpage>–<lpage>184</lpage><pub-id pub-id-type="pmid">26151600</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombard</surname><given-names>JH</given-names></name></person-group>
<article-title>Depression, psychological stress, vascular dysfunction, and cardiovascular disease: thinking outside the barrel</article-title>. <source/>J Appl Physiol. <year>2010</year>;<volume>108</volume>:<fpage>1025</fpage>–<lpage>1026</lpage><pub-id pub-id-type="pmid">20203070</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>MCC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Sousa</surname><given-names>CNS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gomes</surname><given-names>PXL</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry. <year>2016</year>;<volume>64</volume>:<fpage>142</fpage>–<lpage>148</lpage><pub-id pub-id-type="pmid">26265141</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>GS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ximenes</surname><given-names>NC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Sousa</surname><given-names>CNS</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: participation of antioxidant, nitrergic and neurotrophic mechanisms</article-title>. <source/>Schizophr Res. <year>2015</year>;<volume>165</volume>:<fpage>163</fpage>–<lpage>170</lpage><pub-id pub-id-type="pmid">25937462</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Karper</surname><given-names>LP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Seibyl</surname><given-names>JP</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans</article-title>. <source/>Arch Gen Psychiatry. <year>1994</year>;<volume>51</volume>:<fpage>199</fpage>–<lpage>214</lpage><pub-id pub-id-type="pmid">8122957</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafioniatis</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Orfanidou</surname><given-names>MA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Papadopoulou</surname><given-names>ES</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia</article-title>. <source/>Behav Brain Res. <year>2016</year>;<volume>309</volume>:<fpage>14</fpage>–<lpage>21</lpage><pub-id pub-id-type="pmid">27132765</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kampfrath</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Evidence that alpha-lipoic acid inhibits NF-kappaB activation independent of its antioxidant function</article-title>. <source/>Inflamm Res. <year>2011</year>;<volume>60</volume>:<fpage>219</fpage>–<lpage>225</lpage><pub-id pub-id-type="pmid">20927568</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buendia</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Michalska</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Navarro</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Nrf2–ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases</article-title>. <source/>Pharmacol Ther. <year>2016</year>;<volume>157</volume>:<fpage>84</fpage>–<lpage>104</lpage><pub-id pub-id-type="pmid">26617217</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beauloye</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Horman</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bertrand</surname><given-names>L</given-names></name></person-group>
<article-title>Even is better than odd: one fat may conceal another</article-title>. <source/>Am J Physiol Heart Circ Physiol. <year>2015</year>;<volume>309</volume>:<fpage>H1112</fpage>–<lpage>H1114</lpage><pub-id pub-id-type="pmid">26297227</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shenderov</surname><given-names>BA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Midtvedt</surname><given-names>T</given-names></name></person-group>
<article-title>Epigenomic programing: a future way to health?</article-title>
<source/>Microb Ecol Health Dis. <year>2014</year>;<volume>25</volume>:<fpage>24145</fpage></mixed-citation>
</ref>
<ref id="B112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>GE</given-names></name></person-group>
<article-title>Mitonuclear ecology</article-title>. <source/>Mol Biol Evol. <year>2015</year>;<volume>32</volume>:<fpage>1917</fpage>–<lpage>1927</lpage><pub-id pub-id-type="pmid">25931514</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>IG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Williams</surname><given-names>BP</given-names></name></person-group>
<article-title>Evolutionary inference across eukaryotes identifies specific pressures favoring mitochondrial gene retention</article-title>. <source/>Cell Systems. <year>2016</year>;<volume>2</volume>:<fpage>101</fpage>–<lpage>111</lpage><pub-id pub-id-type="pmid">27135164</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkins</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Úbeda</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Van Cleve</surname><given-names>J</given-names></name></person-group>
<article-title>The evolving landscape of imprinted genes in humans and mice: conflict among alleles, genes, tissues, and kin</article-title>. <source/>Bioessays. <year>2016</year>;<volume>38</volume>:<fpage>482</fpage>–<lpage>489</lpage><pub-id pub-id-type="pmid">26990753</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atladóttir</surname><given-names>HÓ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thorsen</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Østergaard</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders</article-title>. <source/>J Autism Dev Disord. <year>2010</year>;<volume>40</volume>:<fpage>1423</fpage>–<lpage>1430</lpage><pub-id pub-id-type="pmid">20414802</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>GB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yim</surname><given-names>YS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wong</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>933</fpage>–<lpage>939</lpage><pub-id pub-id-type="pmid">26822608</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marangoni</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faedda</surname><given-names>GL</given-names></name></person-group>
<article-title>The role of environmental exposures as risk factors for bipolar disorder: a systematic review of longitudinal studies</article-title>. <source/>J Affect Disord. <year>2016</year>;<volume>193</volume>:<fpage>165</fpage>–<lpage>174</lpage><pub-id pub-id-type="pmid">26773919</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brasil</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pereira</surname><given-names>JP</given-names><suffix>Jr.</suffix></name></person-group>, <person-group person-group-type="author"><name><surname>Gabaglia</surname><given-names>CR</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Zika virus infection in pregnant women in Rio de Janeiro—preliminary report</article-title>. <source/>N Engl J Med.
<year>2016</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1056/NEJMoa1602412</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broutet</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Krauer</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Riesen</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Zika virus as a cause of neurologic disorders</article-title>. <source/>N Engl J Med. <year>2016</year>;<volume>374</volume>:<fpage>1506</fpage>–<lpage>1509</lpage><pub-id pub-id-type="pmid">26959308</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>ML</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McAllister</surname><given-names>AK</given-names></name></person-group>
<article-title>Maternal T<sub>H</sub>17 cells take a toll on baby's brain</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>919</fpage>–<lpage>920</lpage><pub-id pub-id-type="pmid">26917755</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Victora</surname><given-names>CG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schuler-Faccini</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matijasevich</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Microcephaly in Brazil: how to interpret reported numbers?</article-title>
<source/>Lancet. <year>2016</year>;<volume>387</volume>:<fpage>621</fpage>–<lpage>623</lpage><pub-id pub-id-type="pmid">26864961</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<article-title>Mind-altering microorganisms: the impact of the gut microbiota on brain and behavior</article-title>. <source/>Nat Rev Neurosci. <year>2012</year>;<volume>13</volume>:<fpage>701</fpage>–<lpage>712</lpage><pub-id pub-id-type="pmid">22968153</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zmora</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zeevi</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Korem</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Taking it personally: personalized utilization of the human microbiome in health and disease</article-title>. <source/>Cell Host Microbe. <year>2016</year>;<volume>19</volume>:<fpage>12</fpage>–<lpage>20</lpage><pub-id pub-id-type="pmid">26764593</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsiardanis</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Diamantaras</surname><given-names>A-A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dessypris</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Cognitive Impairment and dietary habits among elders: the Velestino study</article-title>. <source/>J Med Food. <year>2013</year>;<volume>16</volume>:<fpage>343</fpage>–<lpage>350</lpage><pub-id pub-id-type="pmid">23514229</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babio</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Becerra-Tomás</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martínez-González</surname><given-names>MÁ</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Consumption of yogurt, low-fat milk, and other low-fat dairy products is associated with lower risk of metabolic syndrome incidence in an elderly Mediterranean population</article-title>. <source/>J Nutr. <year>2015</year>;<volume>145</volume>:<fpage>2308</fpage>–<lpage>2316</lpage><pub-id pub-id-type="pmid">26290009</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petra</surname><given-names>AI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Panagiotidou</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hatziagelaki</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation</article-title>. <source/>Clin Ther. <year>2015</year>;<volume>37</volume>:<fpage>984</fpage>–<lpage>995</lpage><pub-id pub-id-type="pmid">26046241</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kemper</surname><given-names>KJ</given-names></name></person-group>
<article-title>Integrative approaches to caring for children with autism</article-title>. <source/>Curr Probl Pediatr Adolesc Health Care.
<year>2016</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1016/j.cppeds.2015.12.004</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenstein</surname><given-names>M</given-names></name></person-group>
<article-title>Living factories of the future</article-title>. <source/>Nature. <year>2016</year>;<volume>531</volume>:<fpage>401</fpage>–<lpage>403</lpage><pub-id pub-id-type="pmid">26983542</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bel</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name></person-group>
<article-title>A bacterial nudge to T-cell function</article-title>. <source/>Nature. <year>2015</year>;<volume>526</volume>:<fpage>328</fpage>–<lpage>330</lpage><pub-id pub-id-type="pmid">26469038</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname><given-names>M</given-names></name></person-group>
<article-title>Microbes aid cancer drugs</article-title>. <source/>Science. <year>2015</year>;<volume>350</volume>:<fpage>614</fpage>–<lpage>615</lpage><pub-id pub-id-type="pmid">26542545</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piñero-Lambea</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ruano-Gallego</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fernández</surname><given-names>LA</given-names></name></person-group>
<article-title>Engineered bacteria as therapeutic agents</article-title>. <source/>Curr Opin Biotechnol. <year>2015</year>;<volume>35</volume>:<fpage>94</fpage>–<lpage>102</lpage><pub-id pub-id-type="pmid">26070111</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vétizou</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pitt</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Daillère</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota</article-title>. <source/>Science. <year>2015</year>;<volume>350</volume>:<fpage>1079</fpage>–<lpage>1084</lpage><pub-id pub-id-type="pmid">26541610</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garber</surname><given-names>K</given-names></name></person-group>
<article-title>Drugging the gut microbiome</article-title>. <source/>Nat Biotechnol. <year>2015</year>;<volume>33</volume>:<fpage>228</fpage>–<lpage>231</lpage><pub-id pub-id-type="pmid">25748907</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kali</surname><given-names>A</given-names></name></person-group>
<article-title>Human microbiome engineering: the future and beyond</article-title>. <source/>J Clin Diagn Res. <year>2015</year>;<volume>9</volume>:<fpage>DEO1</fpage>–<lpage>DEO4</lpage></mixed-citation>
</ref>
<ref id="B135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Foster</surname><given-names>JA</given-names></name></person-group>
<article-title>Psychobiotics and the gut–brain axis: in the pursuit of happiness</article-title>. <source/>Neuropsychiatr Dis Treat. <year>2015</year>;<volume>11</volume>:<fpage>715</fpage>–<lpage>723</lpage><pub-id pub-id-type="pmid">25834446</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escoll</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mondino</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rolando</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy</article-title>. <source/>Nat Rev Microbiol. <year>2016</year>;<volume>14</volume>:<fpage>5</fpage>–<lpage>19</lpage><pub-id pub-id-type="pmid">26594043</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>EC</given-names></name></person-group>
<article-title>Tech investors bet on synthetic biology</article-title>. <source/>Nature. <year>2015</year>;<volume>527</volume>:<fpage>19</fpage><pub-id pub-id-type="pmid">26536936</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvis</surname><given-names>LM</given-names></name></person-group>
<article-title>Harnessing the hordes in the microbiome</article-title>. <source/>Chem Eng News. <year>2015</year>;<volume>93</volume>(<issue>38</issue>):<fpage>12</fpage>–<lpage>19</lpage></mixed-citation>
</ref>
<ref id="B139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pardi</surname><given-names>DS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kelly</surname><given-names>CR</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent <italic>Clostridium difficile</italic> Infection</article-title>. <source/>J Infect Dis.
<year>2016</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1093/infdis/jiv766</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrd</surname><given-names>AL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Segre</surname><given-names>JA</given-names></name></person-group>
<article-title>Adapting Koch's postulates. Criteria for disease causation must take microbial interactions into account</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>224</fpage>–<lpage>226</lpage><pub-id pub-id-type="pmid">26816362</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhusoodanan</surname><given-names>J</given-names></name></person-group>
<article-title>Viral soldiers</article-title>. <source/>Scientist. <year>2016</year>;<volume>30</volume>:<fpage>27</fpage>–<lpage>33</lpage></mixed-citation>
</ref>
<ref id="B142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>JK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group>
<article-title>Transkingdom control of viral infection and immunity in the mammalian intestine</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>aad5872</fpage><pub-id pub-id-type="pmid">26816384</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devkota</surname><given-names>S</given-names></name></person-group>
<article-title>Prescription drugs obscure microbiome analyses. Patient populations should be stratified for medications when looking for gut microbial signatures of disease</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>452</fpage>–<lpage>453</lpage><pub-id pub-id-type="pmid">26823414</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ott</surname><given-names>CM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Quick</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Media ion composition controls regulatory and virulence response of <italic>Salmonella</italic> in spaceflight</article-title>. <source/>PLoS One. <year>2008</year>;<volume>3</volume>:<fpage>e3923</fpage><pub-id pub-id-type="pmid">19079590</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibility</article-title>. <source/>FASEB J. <year>2015</year>;<volume>29</volume>:<fpage>3263</fpage>–<lpage>3273</lpage><pub-id pub-id-type="pmid">25877215</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>LE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Taddeo</surname><given-names>SS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weeks</surname><given-names>BR</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Space environmental factor impacts upon murine colon microbiota and mucosal homeostasis</article-title>. <source/>PLoS One.
<year>2015</year>;<volume>10</volume>:<fpage>e0125792</fpage><pub-id pub-id-type="pmid">26083373</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147</label>
<mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Schierholz</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huot</surname><given-names>D</given-names></name></person-group>
<article-title>NASA astronaut Scott Kelly returns safely to Earth after one-year mission</article-title>. <month>3</month>
<day>2</day>, Release 16-023. Accessed <date-in-citation><month>3</month><day>20</day>, <year>2016</year></date-in-citation>, <uri xlink:href="http://www.nasa.gov/press-release/nasa-astronaut-scott-kelly-returns-safely-to-earth-after-one-year-mission" xlink:type="simple">http://www.nasa.gov/press-release/nasa-astronaut-scott-kelly-returns-safely-to-earth-after-one-year-mission</uri></mixed-citation>
</ref>
<ref id="B148">
<label>148</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kream</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ptacek</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Mitochondria, microbiome and their potential psychiatric modulation</article-title>. <source/>Autism Open Access. <year>2015</year>;<volume>5</volume>:<fpage>2</fpage></mixed-citation>
</ref>
<ref id="B149">
<label>149</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parashar</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Udayabanu</surname><given-names>M</given-names></name></person-group>
<article-title>Gut microbiota regulates key modulators of social behavior</article-title>. <source/>Eur Neuropsychopharmacol. <year>2016</year>;<volume>26</volume>:<fpage>78</fpage>–<lpage>91</lpage><pub-id pub-id-type="pmid">26613639</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RW</given-names></name></person-group>
<article-title>Impact of space flight on bacterial virulence and antibiotic susceptibility</article-title>. <source/>Infect Drug Resist. <year>2015</year>;<volume>8</volume>:<fpage>249</fpage>–<lpage>262</lpage><pub-id pub-id-type="pmid">26251622</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchison</surname><given-names>CA</given-names><suffix>III</suffix></name></person-group>, <person-group person-group-type="author"><name><surname>Chuang</surname><given-names>R-Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Noskov</surname><given-names>VN</given-names></name>, <etal>et al.</etal></person-group>
<source/>Science.
<year>2016</year>;<volume>351</volume>:<fpage>aad6253</fpage><pub-id pub-id-type="pmid">27013737</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>AA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Montague</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cumbers</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Grand challenges in space synthetic biology</article-title>. <source/>JRS Interface. <year>2015</year>;<volume>12</volume>: <fpage>20150803</fpage></mixed-citation>
</ref>
<ref id="B153">
<label>153</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciechonska</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Grob</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Isalan</surname><given-names>M</given-names></name></person-group>
<article-title>From noise to synthetic nucleoli: can synthetic biology achieve new insights?</article-title>
<source/>Integr Biol. <year>2016</year>;<volume>8</volume>:<fpage>383</fpage>–<lpage>393</lpage></mixed-citation>
</ref>
<ref id="B154">
<label>154</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bryce</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Albanese</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The global prevalence of dementia: a systematic review and metaanalysis</article-title>. <source/>Alzheimer's Dement. <year>2013</year>;<volume>9</volume>:<fpage>63</fpage>–<lpage>75</lpage><pub-id pub-id-type="pmid">23305823</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Beal</surname><given-names>MF</given-names></name></person-group>
<article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</article-title>. <source/>Nature. <year>2006</year>;<volume>443</volume>:<fpage>787</fpage>–<lpage>795</lpage><pub-id pub-id-type="pmid">17051205</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currais</surname><given-names>A</given-names></name></person-group>
<article-title>Ageing and inflammation–A central role for mitochondria in brain health and disease</article-title>. <source/>Ageing Res Rev. <year>2015</year>;<volume>21</volume>:<fpage>30</fpage>–<lpage>42</lpage><pub-id pub-id-type="pmid">25684584</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group>
<article-title>Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle</article-title>. <source/>Nat Aging Mech Dis. <year>2015</year>;<volume>1</volume>:<fpage>15003</fpage></mixed-citation>
</ref>
<ref id="B158">
<label>158</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaglio</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brand</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dario</surname><given-names>C</given-names></name></person-group>
<article-title>Fighting dementia in Europe: the time to act is now</article-title>. <source/>Lancet Neurol. <year>2016</year>;<volume>15</volume>:<fpage>452</fpage>–<lpage>454</lpage><pub-id pub-id-type="pmid">26987700</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satizabal</surname><given-names>CL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Beiser</surname><given-names>AS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chouraki</surname><given-names>V</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Incidence of dementia over three decades in the Framingham Heart Study</article-title>. <source/>N Engl J Med. <year>2016</year>;<volume>374</volume>:<fpage>523</fpage>–<lpage>532</lpage><pub-id pub-id-type="pmid">26863354</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y-T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fratiglioni</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matthews</surname><given-names>FE</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Dementia in western Europe: epidemiological evidence and implications for policy making</article-title>. <source/>Lancet Neurol. <year>2016</year>;<volume>15</volume>:<fpage>116</fpage>–<lpage>124</lpage><pub-id pub-id-type="pmid">26300044</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winblad</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Amouyel</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Andrieu</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Defeating Alzheimer's disease and other dementias: a priority for European science and society</article-title>. <source/>Lancet Neurol. <year>2016</year>;<volume>15</volume>:<fpage>455</fpage>–<lpage>532</lpage><pub-id pub-id-type="pmid">26987701</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blanton</surname><given-names>LV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Frese</surname><given-names>SA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Cultivating healthy growth and nutrition through the gut microbiota</article-title>. <source/>Cell. <year>2015</year>;<volume>161</volume>:<fpage>36</fpage>–<lpage>48</lpage><pub-id pub-id-type="pmid">25815983</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koufaris</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sismani</surname><given-names>C</given-names></name></person-group>
<article-title>Modulation of the genome and epigenome of individuals susceptible to autism by environmental risk factors</article-title>. <source/>Int J Mol Sci. <year>2015</year>;<volume>16</volume>:<fpage>8699</fpage>–<lpage>8718</lpage><pub-id pub-id-type="pmid">25903146</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>TR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>
<article-title>Control of brain development, function, and behavior by the microbiome</article-title>. <source/>Cell Host Microbe. <year>2015</year>;<volume>17</volume>:<fpage>565</fpage>–<lpage>576</lpage><pub-id pub-id-type="pmid">25974299</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>C</given-names></name></person-group>
<article-title>Mental health: thinking from the gut</article-title>. <source/>Nature. <year>2015</year>;<volume>518</volume>:<fpage>S12</fpage>–<lpage>S15</lpage><pub-id pub-id-type="pmid">25715275</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millan</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Andrieux</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bartzokis</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Altering the course of schizophrenia: progress and perspectives</article-title>. <source/>Nat Rev Drug Discov.
<year>2016</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1038/nrd.2016.28</pub-id></mixed-citation>
</ref>
<ref id="B167">
<label>167</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oriach</surname><given-names>CS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Robertson</surname><given-names>RC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stanton</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Food for thought: the role of nutrition in the microbiota-gut-brain axis</article-title>. <source/>Clin Nutr Exp. <year>2016</year>;<volume>6</volume>:<fpage>25</fpage>–<lpage>38</lpage></mixed-citation>
</ref>
<ref id="B168">
<label>168</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maslowski</surname><given-names>KM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mackay</surname><given-names>CR</given-names></name></person-group>
<article-title>Diet, gut microbiota and immune responses</article-title>. <source/>Nat Immunol. <year>2011</year>;<volume>12</volume>:<fpage>5</fpage>–<lpage>9</lpage><pub-id pub-id-type="pmid">21169997</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forslund</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hildebrand</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota</article-title>. <source/>Nature. <year>2015</year>;<volume>528</volume>:<fpage>262</fpage>–<lpage>266</lpage><pub-id pub-id-type="pmid">26633628</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de La Serre</surname><given-names>CB</given-names></name></person-group>
<article-title>Gut microbiome-brain communications regulate host physiology and behavior</article-title>. <source/>J Nutr Health Food Sci. <year>2015</year>;<volume>3</volume>:<fpage>1</fpage>–<lpage>12</lpage></mixed-citation>
</ref>
<ref id="B171">
<label>171</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marette</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jobin</surname><given-names>C</given-names></name></person-group>
<article-title>SCFAs take a toll en route to metabolic syndrome</article-title>. <source/>Cell Metab. <year>2015</year>;<volume>22</volume>:<fpage>954</fpage>–<lpage>956</lpage><pub-id pub-id-type="pmid">26636491</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>DF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cain</surname><given-names>DP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rodriguez-Capote</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders</article-title>. <source/>Behav Brain Res. <year>2007</year>;<volume>176</volume>:<fpage>149</fpage>–<lpage>169</lpage><pub-id pub-id-type="pmid">16950524</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173</label>
<mixed-citation publication-type="journal"><collab>MacFabe DF Short-chain fatty acid fermentation products of the gut microbiome</collab>: <article-title>implications in autism spectrum disorders</article-title>. <source/>Microb Ecol Health Dis. <year>2012</year>;<volume>23</volume>:<fpage>19260</fpage></mixed-citation>
</ref>
<ref id="B174">
<label>174</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>D</given-names></name></person-group>
<article-title>Autism: metabolism, mitochondria, and the microbiome</article-title>. <source/>Global Adv Health Med. <year>2013</year>;<volume>2</volume>:<fpage>52</fpage>–<lpage>66</lpage></mixed-citation>
</ref>
<ref id="B175">
<label>175</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galland</surname><given-names>L</given-names></name></person-group>
<article-title>The gut microbiome and the brain</article-title>. <source/>J Med Food,
<year>2014</year>;<volume>17</volume>:<fpage>1261</fpage>–<lpage>1272</lpage><pub-id pub-id-type="pmid">25402818</pub-id></mixed-citation>
</ref>
<ref id="B176">
<label>176</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldani</surname><given-names>AAS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Downs</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Widjaja</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Biomarkers in autism</article-title>. <source/>Front Psychiatry. <year>2014</year>;<volume>5</volume>:<fpage>100</fpage><pub-id pub-id-type="pmid">25161627</pub-id></mixed-citation>
</ref>
<ref id="B177">
<label>177</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foley</surname><given-names>KA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>DF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kavaliers</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: relevance to autism spectrum disorders</article-title>. <source/>Behav Brain Res. <year>2015</year>;<volume>278</volume>:<fpage>244</fpage>–<lpage>256</lpage><pub-id pub-id-type="pmid">25300465</pub-id></mixed-citation>
</ref>
<ref id="B178">
<label>178</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>RE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Slattery</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>DF</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Approaches to studying and manipulating the enteric microbiome to improve autism symptoms</article-title>. <source/>Microb Ecol Health Dis. <year>2015</year>;<volume>26</volume>:<fpage>26878</fpage><pub-id pub-id-type="pmid">25956237</pub-id></mixed-citation>
</ref>
<ref id="B179">
<label>179</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mezzelani</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Landini</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Facchiano</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis</article-title>. <source/>Nutr Neurosci. <year>2015</year>;<volume>18</volume>:<fpage>145</fpage>–<lpage>161</lpage><pub-id pub-id-type="pmid">24621061</pub-id></mixed-citation>
</ref>
<ref id="B180">
<label>180</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shultz</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aziz</surname><given-names>NAB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats</article-title>. <source/>Behav Brain Res. <year>2015</year>;<volume>278</volume>:<fpage>542</fpage>–<lpage>548</lpage><pub-id pub-id-type="pmid">25446754</pub-id></mixed-citation>
</ref>
<ref id="B181">
<label>181</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyarzabal</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bravo-Alonso</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sánchez-Aragó</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Mitochondrial response to the BCKDK-deficiency: some clues to understand the positive dietary response in this form of autism</article-title>. <source/>BBA-Mol Basis Dis. <year>2016</year>;<volume>1862</volume>:<fpage>592</fpage>–<lpage>600</lpage></mixed-citation>
</ref>
<ref id="B182">
<label>182</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>PGC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Domingues</surname><given-names>DD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Carvalho</surname><given-names>LA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neurotrophic factors in Parkinson's disease are regulated by exercise: evidence-based practice</article-title>. <source/>J Neurol Sci. <year>2016</year>;<volume>363</volume>:<fpage>5</fpage>–<lpage>15</lpage><pub-id pub-id-type="pmid">27000212</pub-id></mixed-citation>
</ref>
<ref id="B183">
<label>183</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwynette</surname><given-names>MF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Warren</surname><given-names>NJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Warthen</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Yoga as an intervention for patients with autism spectrum disorder: a review of the evidence and future directions</article-title>. <source/>Autism Open Access. <year>2015</year>;<volume>5</volume>:<fpage>3</fpage></mixed-citation>
</ref>
<ref id="B184">
<label>184</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duzel</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>van Praag</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sendtner</surname><given-names>M</given-names></name></person-group>
<article-title>Can physical exercise in old age improve memory and hippocampal function?</article-title>
<source/>Brain. <year>2016</year>;<volume>139</volume>:<fpage>662</fpage>–<lpage>673</lpage><pub-id pub-id-type="pmid">26912638</pub-id></mixed-citation>
</ref>
<ref id="B185">
<label>185</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hall</surname><given-names>PA</given-names></name></person-group>
<article-title>Hatha yoga and executive function: a systematic review</article-title>. <source/>J Altern Complement Med. <year>2016</year>;<volume>22</volume>:<fpage>125</fpage>–<lpage>133</lpage><pub-id pub-id-type="pmid">26398441</pub-id></mixed-citation>
</ref>
<ref id="B186">
<label>186</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Mahony</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Early-life adversity and brain development: is the microbiome a missing piece of the puzzle?</article-title>
<source/>Neuroscience. <year>2015</year>;<volume>322</volume> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.09.068</pub-id></mixed-citation>
</ref>
<ref id="B187">
<label>187</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charbonneau</surname><given-names>MR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Donnell</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blanton</surname><given-names>LV</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition</article-title>. <source/>Cell. <year>2016</year>;<volume>164</volume>:<fpage>859</fpage>–<lpage>871</lpage><pub-id pub-id-type="pmid">26898329</pub-id></mixed-citation>
</ref>
<ref id="B188">
<label>188</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>CSM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Callaghan</surname><given-names>BL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kan</surname><given-names>JM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The lasting impact of early-life adversity on individuals and their descendants: potential mechanisms and hope for intervention</article-title>. <source/>Genes Brain Behav. <year>2016</year>;<volume>15</volume>:<fpage>155</fpage>–<lpage>168</lpage><pub-id pub-id-type="pmid">26482536</pub-id></mixed-citation>
</ref>
<ref id="B189">
<label>189</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennisi</surname><given-names>E</given-names></name></person-group>
<article-title>The right gut microbes help infants grow</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>582</fpage><pub-id pub-id-type="pmid">26912698</pub-id></mixed-citation>
</ref>
<ref id="B190">
<label>190</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanton</surname><given-names>LV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Charbonneau</surname><given-names>MR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Salih</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>aad3311</fpage><pub-id pub-id-type="pmid">26912898</pub-id></mixed-citation>
</ref>
<ref id="B191">
<label>191</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarzer</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Makki</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Storelli</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group>
<article-title><italic>Lactobacillus plantarum</italic> strain maintains growth of infant mice during chronic undernutrition</article-title>. <source/>Science. <year>2016</year>;<volume>351</volume>:<fpage>854</fpage>–<lpage>857</lpage><pub-id pub-id-type="pmid">26912894</pub-id></mixed-citation>
</ref>
<ref id="B192">
<label>192</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaiss</surname><given-names>CA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Elinav</surname><given-names>E</given-names></name></person-group>
<article-title>Exploring new horizons in microbiome research</article-title>. <source/>Cell Host Microbe. <year>2014</year>;<volume>15</volume>:<fpage>662</fpage>–<lpage>667</lpage><pub-id pub-id-type="pmid">24922569</pub-id></mixed-citation>
</ref>
<ref id="B193">
<label>193</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ash</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mueller</surname><given-names>K</given-names></name></person-group>
<article-title>Manipulating the microbiota</article-title>. <source/>Science. <year>2016</year>;<volume>352</volume>:<fpage>531</fpage></mixed-citation>
</ref>
<ref id="B194">
<label>194</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The emerging landscape of salivary diagnostics</article-title>. <source/>Periodontol 2000. <year>2016</year>;<volume>70</volume>:<fpage>38</fpage>–<lpage>52</lpage>
<pub-id pub-id-type="pmid">26662481</pub-id></mixed-citation>
</ref>
</ref-list>
<ref-list>
<p><bold>Cite this article as:</bold> Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, Steliou K (2016) Microbiota and neurological disorders: a gut feeling, <italic>BioResearch Open Access</italic> 5:1, 137–145, DOI: 10.1089/biores.2016.0010.</p>
</ref-list>
<glossary>
<title>Abbreviations Used</title>
<def-list>
<def-item>
<term id="G1">ALA</term>
<def>
<p>α-lipoic acid</p>
</def>
</def-item>
<def-item>
<term id="G2">ASD</term>
<def>
<p>autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term id="G3">HDAC</term>
<def>
<p>histone deacetylase</p>
</def>
</def-item>
<def-item>
<term id="G4">ILOD</term>
<def>
<p>idiopathic late-onset dementia</p>
</def>
</def-item>
<def-item>
<term id="G5">MCFA</term>
<def>
<p>medium-chain fatty acid</p>
</def>
</def-item>
<def-item>
<term id="G6">mtDNA</term>
<def>
<p>mitochondrial DNA</p>
</def>
</def-item>
<def-item>
<term id="G7">NF-κB</term>
<def>
<p>nuclear factor kappa-B</p>
</def>
</def-item>
<def-item>
<term id="G8">Nrf2</term>
<def>
<p>nuclear factor (erythroid-derived 2)-like 2</p>
</def>
</def-item>
<def-item>
<term id="G9">OXPHOS</term>
<def>
<p>oxidative phosphorylation</p>
</def>
</def-item>
<def-item>
<term id="G10">PPA</term>
<def>
<p>propionic acid</p>
</def>
</def-item>
<def-item>
<term id="G11">SCFA</term>
<def>
<p>short-chain fatty acid</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>